share_log

Pieris Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Checkpoint Capital (Master) Fund, LP(6.0%),Checkpoint Capital, LP(6.0%), etc.

Pieris Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Checkpoint Capital (Master) Fund, LP(6.0%),Checkpoint Capital, LP(6.0%)等

SEC announcement ·  2023/06/09 17:40
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息